Skip to content

Vericel VCEL Free cash flow margin

Free cash flow margin at other companies

Stryker logo
StrykerSYK
18.1%+2.7pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
17.3%-1.6pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
30.9%+12.7pp
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-563.9%-954pp
Globus Medical logo
Globus MedicalGMED
19.7%-1.1pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on trailing twelve months.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's free cash flow margin?
Vericel (VCEL) reported free cash flow margin of 16.3% in Q1 2026.
What is the long-term trend for Vericel's free cash flow margin?
Over 3 years (2021 to 2025), Vericel's free cash flow margin has grown at a -12.8% compound annual growth rate (CAGR), from 13.5% to 9%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.